Micromet, sanofi in cancer antibody deal

Micromet Inc. (NASDAQ:MITI) partnered with sanofi-aventis Group (Euronext:SAN; NYSE:SNY) to use the biotech's bispecific T cell engager (BiTE) technology to discover and develop a BiTE antibody agains...